文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

载甲氨蝶呤的壳聚糖和乙二醇壳聚糖纳米粒:一种将抗癌药物递送至脑肿瘤的有前途的策略。

Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors.

机构信息

Department of Pharmaceutical Chemistry, School of Pharmacy, University of Bari, Italy.

出版信息

AAPS PharmSciTech. 2011 Dec;12(4):1302-11. doi: 10.1208/s12249-011-9695-x. Epub 2011 Sep 27.


DOI:10.1208/s12249-011-9695-x
PMID:21948322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3225549/
Abstract

Brain tumor treatment employing methotrexate (MTX) is limited by the efflux mechanism of Pg-p on the blood-brain barrier. We aimed to investigate MTX-loaded chitosan or glycol chitosan (GCS) nanoparticles (NPs) in the presence and in the absence of a coating layer of Tween 80 for brain delivery of MTX. The effect of a low Tween 80 concentration was evaluated. MTX NPs were formulated following the ionic gelation technique and size and zeta potential measurements were acquired. Transport across MDCKII-MDR1 monolayer and cytotoxicity studies against C6 glioma cell line were also performed. Cell/particles interaction was visualized by confocal microscopy. The particles were shown to be cytotoxic against C6 cells line and able to overcome MDCKII-MDR1 cell barrier. GCS-based NPs were the most cytotoxic NPs. Confocal observations highlighted the internalization of Tween 80-coated fluorescent NPs more than Tween 80-uncoated NPs. The results suggest that even a low concentration of Tween 80 is sufficient for enhancing the transport of MTX from the NPs across MDCKII-MDR1 cells. The nanocarriers represent a promising strategy for the administration of MTX to brain tumors which merits further investigations under in vivo conditions.

摘要

脑肿瘤的治疗采用甲氨蝶呤(MTX),但受到血脑屏障上 Pg-p 外排机制的限制。我们旨在研究载甲氨蝶呤的壳聚糖或乙二醇壳聚糖(GCS)纳米颗粒(NPs),并在存在和不存在吐温 80 涂层的情况下用于 MTX 的脑部递药。评估了低浓度吐温 80 的效果。采用离子凝胶化技术制备 MTX NPs,并进行了粒径和 Zeta 电位测量。还进行了跨 MDCKII-MDR1 单层的转运和针对 C6 神经胶质瘤细胞系的细胞毒性研究。通过共聚焦显微镜观察细胞/颗粒的相互作用。结果表明,这些颗粒对 C6 细胞系具有细胞毒性,并能够克服 MDCKII-MDR1 细胞屏障。基于 GCS 的 NPs 是最具细胞毒性的 NPs。共聚焦观察突出了吐温 80 涂层荧光 NPs 的内化程度超过了未涂层 NPs。结果表明,即使是低浓度的吐温 80 也足以增强 MTX 从 NPs 到 MDCKII-MDR1 细胞的转运。这些纳米载体为脑肿瘤中 MTX 的给药提供了一种很有前途的策略,值得在体内条件下进一步研究。

相似文献

[1]
Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors.

AAPS PharmSciTech. 2011-9-27

[2]
Glucose cryoprotectant affects glutathione-responsive antitumor drug release from polysaccharide nanoparticles.

Eur J Pharm Biopharm. 2015-6

[3]
Lactobionic acid-modified thymine-chitosan nanoparticles as potential carriers for methotrexate delivery.

Carbohydr Res. 2021-3

[4]
β-Cyclodextrin-based biodegradable dendrimers for drug delivery.

J Control Release. 2011-11-30

[5]
Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.

Drug Dev Ind Pharm. 2019-6-3

[6]
Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.

Drug Deliv. 2013-10-10

[7]
Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.

Pharm Res. 2011-12-14

[8]
Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.

Mol Pharm. 2014-7-7

[9]
Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles.

Int J Nanomedicine. 2018-9-24

[10]
Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.

Pharm Dev Technol. 2018-1-18

引用本文的文献

[1]
Uptake and Inhibition of P-Glycoprotein-Mediated Efflux Evaluation of Encapsulated Methotrexate Chitosan and Hypromellose Phthalate Nanoparticles for Potential Glioblastoma Treatment.

Pharmaceutics. 2025-2-12

[2]
Enhanced Cytotoxic Effect of Doxorubicin Conjugated to Glutathione-Stabilized Gold Nanoparticles in Canine Osteosarcoma-In Vitro Studies.

Molecules. 2021-6-8

[3]
Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers.

Pharmaceutics. 2020-10-23

[4]
Chitosan-Based Non-viral Gene and Drug Delivery Systems for Brain Cancer.

Front Neurol. 2020-7-30

[5]
Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers.

Int J Mol Sci. 2020-5-14

[6]
Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles.

Int J Nanomedicine. 2018-9-24

[7]
Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).

Int J Nanomedicine. 2018-3-12

[8]
Brain Localization and Neurotoxicity Evaluation of Polysorbate 80-Modified Chitosan Nanoparticles in Rats.

PLoS One. 2015-8-6

[9]
Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates.

Am J Nucl Med Mol Imaging. 2014-8-15

[10]
Preparation and assessment of chitosan-coated superparamagnetic Fe3O4 nanoparticles for controlled delivery of methotrexate.

Res Pharm Sci. 2013-1

本文引用的文献

[1]
A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.

Eur J Pharm Biopharm. 2010-1-25

[2]
Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.

Eur J Pharm Biopharm. 2009-9-13

[3]
New strategies to deliver anticancer drugs to brain tumors.

Expert Opin Drug Deliv. 2009-10

[4]
The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs.

Int J Pharm. 2009-6-22

[5]
Therapeutic challenges in primary CNS lymphoma.

Lancet Neurol. 2009-6

[6]
In vivo, in vitro and in silico methods for small molecule transfer across the BBB.

J Pharm Sci. 2009-12

[7]
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

J Control Release. 2009-7-1

[8]
The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione.

Eur J Pharm Biopharm. 2009-3-10

[9]
Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.

Curr Top Med Chem. 2009

[10]
Analytical characterization of chitosan nanoparticles for peptide drug delivery applications.

Anal Bioanal Chem. 2009-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索